Can-Fite grants 24,000 options to CSO

Can-Fite BioPharma Ltd. reported that Chief Scientific Officer Pnina Fishman received a grant of 24,000 options to purchase ordinary shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Can-Fite BioPharma Ltd. reported that Chief Scientific Officer Pnina Fishman received a grant of 24,000 options to purchase ordinary shares. The options have an exercise price of $2.043 per share and bring her reported option holdings to 34,299 options after the grant.

The options vest in 16 equal quarterly installments from September 4, 2026 through April 6, 2030, conditional on continued service. To qualify for tax benefits under Section 102 of the Israeli Tax Ordinance, the securities are registered in a trustee’s name, and the exercise price was converted from NIS 5.94 using a NIS 2.908 = $1.00 exchange rate.

Insider Trade Summary

Grant/Award: 24,000 shares

Grant/Award 1 txn

Insider Fishman Pnina

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
Grant/Award	Options to Purchase Ordinary Shares	24,000	$0.00	$0.00

Holdings After Transaction: Options to Purchase Ordinary Shares — 34,299 contracts (Direct)

Footnotes (3)

F1. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2003 Share Option Plan, 2013 Share Option Plan and 2023 Share Option Plan must be registered in the name of a trustee.
F2. The options will vest in sixteen equal quarterly installments beginning 09/04/2026 and ending 04/06/2030, subject to the Reporting Person's continued service to the Issuer as of such vesting date.
F3. The exercise price of this option, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 5.94, is presented in the table in U.S. dollars ("USD") based on the exchange rate reported by the Bank of Israel on June 5, 2026, which was NIS 2.908 = USD 1.00.

Key Figures

Options granted: 24,000 options Exercise price: $2.043 per share Options after grant: 34,299 options +4 more

7 metrics

Options granted 24,000 options Grant of options to purchase ordinary shares on June 4, 2026

Exercise price $2.043 per share Exercise price for the granted options, reported in USD

Options after grant 34,299 options Total option holdings reported following the transaction

Original NIS exercise price NIS 5.94 Exercise price originally denominated in New Israeli Shekels

FX rate used NIS 2.908 = $1.00 Bank of Israel exchange rate on June 5, 2026 for USD reporting

Vesting schedule length 16 quarterly installments Vesting from September 4, 2026 to April 6, 2030

Option expiration June 4, 2036 Expiration date of the granted options

Key Terms

Section 102 of the Israeli Tax Ordinance, Share Option Plan, vesting, exercise price, +1 more

5 terms

Section 102 of the Israeli Tax Ordinance regulatory

"To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance"

vesting financial

"The options will vest in sixteen equal quarterly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"The exercise price of this option, originally denominated in New Israeli Shekels"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

trustee regulatory

"must be registered in the name of a trustee"

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Can-Fite (CANF) disclose for Pnina Fishman?

Can-Fite disclosed that Chief Scientific Officer Pnina Fishman received a grant of 24,000 stock options. These options allow her to purchase ordinary shares and are a form of equity compensation, not an open-market share purchase or sale.

What are the key terms of the 24,000 options granted by Can-Fite (CANF)?

The grant covers 24,000 options to purchase ordinary shares at an exercise price of $2.043 per share. Following this award, Fishman’s reported option holdings total 34,299 options, reflecting her compensation-linked derivative position with the company.

How do the new Can-Fite (CANF) options for Pnina Fishman vest over time?

The options vest in sixteen equal quarterly installments starting September 4, 2026 and ending April 6, 2030. Each installment requires Pnina Fishman to remain in service with Can-Fite through the applicable vesting date for those options to become exercisable.

How was the Can-Fite (CANF) option exercise price determined and reported?

The option’s original exercise price was set at NIS 5.94 and then translated into $2.043 per share. Can-Fite used the Bank of Israel’s June 5, 2026 exchange rate of NIS 2.908 for each U.S. dollar to present the U.S. dollar figure.

Why are Can-Fite (CANF) employee options held in a trustee’s name?

The filing states that, to qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under Can-Fite’s option plans must be registered in a trustee’s name. This structure is tied to Israeli employee equity tax rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/08/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fishman Pnina

(Last)

(First)

(Middle)

C/O CAN-FITE BIOPHARMA LTD.

26 BEN GURION STREET

(Street)

RAMAT GAN

5257346

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Can-Fite BioPharma Ltd. [ CANF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol
[CANF.TA]

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options to Purchase Ordinary Shares⁽¹⁾⁽²⁾	$2.043⁽³⁾	06/04/2026		A		24,000		09/04/2026	06/04/2036	Ordinary Shares	24,000	$0	34,299	D

Explanation of Responses:

1. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2003 Share Option Plan, 2013 Share Option Plan and 2023 Share Option Plan must be registered in the name of a trustee.

2. The options will vest in sixteen equal quarterly installments beginning 09/04/2026 and ending 04/06/2030, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

3. The exercise price of this option, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 5.94, is presented in the table in U.S. dollars ("USD") based on the exchange rate reported by the Bank of Israel on June 5, 2026, which was NIS 2.908 = USD 1.00.

	/s/ Pnina Fishman	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR